VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 112 filers reported holding VISTAGEN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $10,201 | -20.6% | 82,259 | -34.1% | 0.00% | – |
| Q4 2022 | $12,849 | -80.8% | 124,747 | -71.8% | 0.00% | – |
| Q3 2022 | $67,000 | +857.1% | 442,364 | +5530.9% | 0.00% | – |
| Q2 2022 | $7,000 | -96.4% | 7,856 | -94.9% | 0.00% | – |
| Q1 2022 | $192,000 | -81.6% | 155,077 | -71.0% | 0.00% | – |
| Q4 2021 | $1,044,000 | +52100.0% | 535,334 | +63935.2% | 0.00% | – |
| Q3 2021 | $2,000 | -71.4% | 836 | -63.9% | 0.00% | – |
| Q2 2021 | $7,000 | +600.0% | 2,316 | +200.4% | 0.00% | – |
| Q3 2019 | $1,000 | – | 771 | +12750.0% | 0.00% | – |
| Q2 2018 | $0 | – | 6 | -91.5% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 71 | -89.1% | 0.00% | – |
| Q2 2016 | $3,000 | – | 649 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 11,728,033 | $36,943,000 | 14.76% |
| VR Adviser, LLC | 16,047,286 | $50,549,000 | 6.13% |
| COMMODORE CAPITAL LP | 3,331,315 | $10,494,000 | 3.66% |
| Ghost Tree Capital, LLC | 2,000,000 | $6,300,000 | 1.73% |
| EPIQ PARTNERS, LLC | 932,956 | $2,939,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 4,080,673 | $12,854,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 615,547 | $1,939,000 | 0.86% |
| HighVista Strategies LLC | 308,096 | $971,000 | 0.69% |
| NEA Management Company, LLC | 16,302,596 | $51,353,000 | 0.67% |
| Nicholas Investment Partners, LP | 2,753,880 | $8,675,000 | 0.54% |